The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan.


Journal

International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 27 02 2020
accepted: 11 06 2020
pubmed: 3 7 2020
medline: 26 11 2020
entrez: 3 7 2020
Statut: ppublish

Résumé

Owing to the low incidence of adenoid cystic carcinoma (AdCC), reliable survival estimates and prognostic factors remained unclarified. In this multi-institutional retrospective analysis, we collected 192 AdCC cases, and investigated the impact of clinicopathological factors on clinical outcomes of the patients. All AdCC cases were of salivary gland origin and were surgically treated with curative intent. Diagnoses of AdCC were validated by a central pathology review by expert pathologists. The 5-year overall survival (OS) and disease-free survival (DFS) rates were 92.5 and 50.0%, respectively. Treatment failure occurred in 89 patients (46%) with the distant failures in 65 (34%). Multivariate analysis indicated that pN2 and a pathologically positive surgical margin were independent prognostic factors for both OS and DFS. Histological grade III was an independent prognostic factor for OS. A primary site in the submandibular gland, pT3/4, pN1, and histological grade II were independent prognostic factors for DFS. Postoperative radiation therapy (PORT) improved the locoregional control (LRC) rate. Prophylactic neck dissection was not associated with a better OS or better LRC among patients with cN0. Facial nerve dissection did not improve clinical outcomes in parotid AdCC cases without facial nerve palsy. A higher TN classification, a pathologically positive surgical margin, and a higher histological grade were associated with a lower OS. PORT improved LRC rates but neck dissection failed to improve clinical outcomes in patients with cN0. As the distant metastasis was frequent, effective systemic therapy is imperative to improve the survival of AdCC patients.

Sections du résumé

BACKGROUND BACKGROUND
Owing to the low incidence of adenoid cystic carcinoma (AdCC), reliable survival estimates and prognostic factors remained unclarified.
METHODS METHODS
In this multi-institutional retrospective analysis, we collected 192 AdCC cases, and investigated the impact of clinicopathological factors on clinical outcomes of the patients. All AdCC cases were of salivary gland origin and were surgically treated with curative intent. Diagnoses of AdCC were validated by a central pathology review by expert pathologists.
RESULTS RESULTS
The 5-year overall survival (OS) and disease-free survival (DFS) rates were 92.5 and 50.0%, respectively. Treatment failure occurred in 89 patients (46%) with the distant failures in 65 (34%). Multivariate analysis indicated that pN2 and a pathologically positive surgical margin were independent prognostic factors for both OS and DFS. Histological grade III was an independent prognostic factor for OS. A primary site in the submandibular gland, pT3/4, pN1, and histological grade II were independent prognostic factors for DFS. Postoperative radiation therapy (PORT) improved the locoregional control (LRC) rate. Prophylactic neck dissection was not associated with a better OS or better LRC among patients with cN0. Facial nerve dissection did not improve clinical outcomes in parotid AdCC cases without facial nerve palsy.
CONCLUSIONS CONCLUSIONS
A higher TN classification, a pathologically positive surgical margin, and a higher histological grade were associated with a lower OS. PORT improved LRC rates but neck dissection failed to improve clinical outcomes in patients with cN0. As the distant metastasis was frequent, effective systemic therapy is imperative to improve the survival of AdCC patients.

Identifiants

pubmed: 32613404
doi: 10.1007/s10147-020-01731-9
pii: 10.1007/s10147-020-01731-9
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1774-1785

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 18H02633
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 17K08746

Auteurs

Daisuke Kawakita (D)

Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Takayuki Murase (T)

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-ku, Nagoya, 467-8601, Japan.

Kaori Ueda (K)

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-ku, Nagoya, 467-8601, Japan.
Department of Maxillofacial Surgery, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan.

Satoshi Kano (S)

Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Yuichiro Tada (Y)

Department of Head and Neck Oncology and Surgery, Mita Hospital, International University of Health and Welfare, Tokyo, Japan.

Kiyoaki Tsukahara (K)

Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.

Kenji Okami (K)

Department of Otolaryngology-Head and Neck Surgery, Tokai University School of Medicine, Isehara, Japan.

Tetsuro Onitsuka (T)

Division of Head and Neck Surgery, Shizuoka Cancer Center, Mishima, Japan.

Yasushi Fujimoto (Y)

Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Takuma Matoba (T)

Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Kazuo Sakurai (K)

Department of Otorhinolaryngology, Fujita Health University, Toyoake, Japan.

Toru Nagao (T)

Department of Maxillofacial Surgery, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan.

Nobuhiro Hanai (N)

Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Ryo Kawata (R)

Department of and Otorhinolaryngology-Head and Neck Surgery, Osaka Medical College, Takatsuki, Japan.

Naohito Hato (N)

Department of Otolaryngology, Ehime University School of Medicine, Matsuyama, Japan.

Ken-Ichi Nibu (KI)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Makoto Urano (M)

Department of Diagnostic Pathology, School of Medicine, Fujita Health University, Toyoake, Japan.

Ken-Ichi Taguchi (KI)

Department of Pathology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

Masato Nakaguro (M)

Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.

Kimihide Kusafuka (K)

Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan.

Hidetaka Yamamoto (H)

Department of Anatomic Pathology, Graduate of School of Medical Science, Kyushu University, Fukuoka, Japan.

Toshitaka Nagao (T)

Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.

Hiroshi Inagaki (H)

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-ku, Nagoya, 467-8601, Japan. hinagaki@med.nagoya-cu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH